Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2024 ∙ Asgedom, Y. S. Kebede, T. M. Seifu, B. L. Mare, K. U. Asmare, Z. A. Asebe, H. A. Kase, B. F. Shibeshi, A. H. Tebeje, T. M. Sabo, K. G. Fente, B. M. Lombebo, A. A. Koyira, M. M. Kassie, G. A.
Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis
Africa Adolescents Human papillomavirus (HPV) Coverage
Rating:
Not applicable
2024 ∙ Motamed, H. Yari, F. Javadirad, E. Golmohammadi, S. Alimoradi, S. Naleini, R. Chegene Lorestani, R. Nemati Zargaran, F. Rostamian, M.
Human vaccine candidates for infections caused by Klebsiella pneumoniae: A systematic review
All age groups Efficacy/effectiveness Safety
Rating:
Critically low
2024 ∙ Li, X. Z. Li, Y. W. Huang, C. Y. Liu, J. L. Liu, R. B. Zhang, Z. X. Yan, J. Z. Zhang, C.
Humoral immunity and safety of respiratory virus vaccines in systemic lupus erythematosus population: a meta-analysis based on twenty-five observational studies
Adults Older adults COVID-19 Influenza Efficacy/effectiveness Safety
Rating:
Critically low
2024 ∙ Ferrara, P. Losa, L. Mantovani, L. G. Ambrosioni, J. Aguero, F.
Humoral immunogenicity of primary yellow fever vaccination in infants and children: a systematic review, meta-analysis and meta-regression
Newborn Children Yellow fever Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Kong, W. Y. Oh, N. L. Kennedy, K. L. Carlson, R. B. Liu, A. Ozawa, S. Brewer, N. T. Gilkey, M. B.
Identifying Healthcare Professionals With Lower Human Papillomavirus (HPV) Vaccine Recommendation Quality: A Systematic Review
Americas United States of America Healthcare workers Human papillomavirus (HPV) Acceptance
Rating:
Not applicable
2024 ∙ Alper, L. Oron, Y. Handzel, O. Abu-Eta, R. Muhanna, N. Ungar, O. J.
Idiopathic sudden sensorineural hearing loss after COVID-19 vaccination: a systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Critically low
2024 ∙ Lamichhane, P. Khalid, H. Siviyachan, C. K. Zafar, S. Prasanth, M. Khanal, K. Agrawal, A. Kaur Jhajj, L.
Immediate impacts of COVID-19 vaccination on glycemic control in type 1 diabetes mellitus: a systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Low
2024 ∙ Hua, T. Fan, R. Fan, Y. Chen, F.
Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Olakunde, B. O. Ifeorah, I. M. Adeyinka, D. A. Olakunde, O. A. Ogundipe, T. Olawepo, J. O. Ezeanolue, E. E.
Immune response to hepatitis B vaccine among children under 5 years in Africa: a meta-analysis
Africa Children Newborn Hepatitis B Efficacy/effectiveness Administration
Rating:
Critically low
2024 ∙ Chue, W. X. Lienardi, L. A. Tan, T. Q. W. Kadir, I. A. Lam, J. C. M.
Immune thrombocytopenia exacerbation post COVID-19 vaccination: a systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Low
Loading...